BiotechTube
Home/Keapstone Therapeutics/Dame Professor Pamela Shaw
DP

Dame Professor Pamela Shaw

Co-Founder, Director of SITraN

Keapstone Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesParkinson's DiseaseAmyotrophic Lateral Sclerosis (ALS)

Keapstone Therapeutics Pipeline

DrugIndicationPhase
Nrf2 Activator ProgramParkinson's DiseasePre-clinical

Leadership Team at Keapstone Therapeutics

DR
Dr Richard Mead
Co-Founder, Board Member, Senior Lecturer at SITraN
RM
Ross McMaster
Company Secretary, Board Member, Financial Consultant
AR
Arthur Roach
Board Member, Director of Research at Parkinson's UK
View full Keapstone Therapeutics profile